Hemply Balance Holding
0.02 SEK
0.00 %
Less than 1K followers
HMPLY
Nordic SME
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Hemply Balance Holding
P/B
Median 2021-2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share price (SEK) | 5.89 | 0.83 | 0.05 | 0.04 | 0.03 |
| Shares | 6.8 | 8.1 | 25.4 | 156.9 | 156.9 |
| Market cap | 40.2 | 6.8 | 1.1 | 6.1 | 5.3 |
| Enterprise value | 37.7 | - | - | - | - |
| EV/S | 16.3 | - | - | - | - |
| EV/EBITDA | neg. | - | - | - | - |
| EV/EBIT | neg. | - | - | - | - |
| P/E | neg. | neg. | neg. | neg. | - |
| P/B | 11.91 | 2.61 | 3.10 | 5.23 | 7.70 |
| P/S | 17.4 | 1.5 | 0.5 | 5.3 | 6.4 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 61.5 % | 76.2 % | 23.7 % | 86.0 % | 74.2 % |
| Gearing ratio | - | - | - | - | - |